• 1. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Aryl halides Aryl bromides

Introduction to 4-Bromo-1-cyclopentyl-3-(trifluoromethyl)pyrazole (CAS No. 1437794-36-9)

4-Bromo-1-cyclopentyl-3-(trifluoromethyl)pyrazole (CAS No. 1437794-36-9) is a versatile compound with significant potential in various chemical and pharmaceutical applications. This compound belongs to the class of pyrazoles, which are widely studied for their diverse biological activities, including anti-inflammatory, analgesic, and antitumor properties. The unique combination of a bromo substituent, a cyclopentyl group, and a trifluoromethyl group in its structure makes it an intriguing molecule for both academic research and industrial development.

The bromo substituent in 4-Bromo-1-cyclopentyl-3-(trifluoromethyl)pyrazole plays a crucial role in its reactivity and biological activity. Bromine is a halogen that can participate in various chemical reactions, such as nucleophilic substitution and coupling reactions. This makes the compound a valuable intermediate in the synthesis of more complex molecules. Recent studies have shown that brominated compounds can exhibit enhanced pharmacological properties, making them attractive candidates for drug development.

The cyclopentyl group in 4-Bromo-1-cyclopentyl-3-(trifluoromethyl)pyrazole adds structural complexity and rigidity to the molecule. Cycloalkyl groups are known to influence the conformational flexibility and lipophilicity of organic compounds, which are important factors in determining their biological activity and pharmacokinetic properties. Research has demonstrated that cycloalkyl-substituted pyrazoles can exhibit improved binding affinity to target proteins, making them promising leads for drug discovery.

The trifluoromethyl group is another key feature of 4-Bromo-1-cyclopentyl-3-(trifluoromethyl)pyrazole. Trifluoromethyl groups are highly electronegative and can significantly affect the electronic properties of a molecule. This group is often used to enhance the metabolic stability and bioavailability of drug candidates. Studies have shown that trifluoromethyl-substituted compounds can exhibit enhanced potency and selectivity, making them valuable for developing new therapeutic agents.

In the context of pharmaceutical research, 4-Bromo-1-cyclopentyl-3-(trifluoromethyl)pyrazole has been investigated for its potential as a lead compound in drug discovery programs. Its unique structural features make it an attractive starting point for the synthesis of more complex molecules with desired biological activities. For example, recent studies have explored the use of this compound as a scaffold for developing new anti-inflammatory drugs. The bromo substituent can be replaced with other functional groups to fine-tune the pharmacological properties of the resulting molecules.

Additionally, 4-Bromo-1-cyclopentyl-3-(trifluoromethyl)pyrazole has shown promise in the development of antitumor agents. The combination of its bromo, cyclopentyl, and trifluoromethyl groups provides a unique set of properties that can be exploited to design molecules with enhanced antiproliferative activity against cancer cells. Preclinical studies have demonstrated that derivatives of this compound can inhibit key signaling pathways involved in tumor growth and metastasis.

From a synthetic chemistry perspective, 4-Bromo-1-cyclopentyl-3-(trifluoromethyl)pyrazole can be prepared through various methods, including metal-catalyzed cross-coupling reactions and multistep synthetic sequences. These synthetic routes allow for the efficient production of this compound on both laboratory and industrial scales. The ability to synthesize this compound reliably is crucial for its widespread use in research and development.

In conclusion, 4-Bromo-1-cyclopentyl-3-(trifluoromethyl)pyrazole (CAS No. 1437794-36-9) is a multifaceted compound with significant potential in both academic research and pharmaceutical applications. Its unique structural features make it an attractive candidate for developing new therapeutic agents with improved pharmacological properties. Ongoing research continues to uncover new applications and derivatives of this compound, further highlighting its importance in the field of chemical biology and medicinal chemistry.

• 1437794-44-9(4-Bromo-1-propyl-3-(trifluoromethyl)pyrazole)
• 1437794-58-5(4-Bromo-1-butyl-3-(trifluoromethyl)pyrazole)
• 2092516-13-5(4-Bromo-1-isobutyl-5-methyl-3-(trifluoromethyl)-1H-pyrazole)
• 2090575-11-2(4-Bromo-1-isopropyl-5-methyl-3-(trifluoromethyl)-1H-pyrazole)
• 1006320-16-6(3-3-(trifluoromethyl)-1H-pyrazol-1-ylpentan-1-amine)
• 1845690-56-3(4-Bromo-1-isopentyl-3-(trifluoromethyl)pyrazole)
• 1437794-62-1(4-Bromo-1-isobutyl-3-(trifluoromethyl)pyrazole)
• 1426958-33-9(4-bromo-1-(propan-2-yl)-3-(trifluoromethyl)-1H-pyrazole)
• 1469202-47-8(1-CYCLOPENTYL-3-(TRIFLUOROMETHYL)PYRAZOLE)
• 1245772-68-2(4-Bromo-1-ethyl-3-(trifluoromethyl)pyrazole)